The adaptor protein Grb2 is a key element of mitogenetically important signaling pathways. With its SH2 domain it binds to upstream targets while its SH3 domains bind to downstream proteins thereby relaying signals from the cell membranes to the nucleus. The Grb2 SH2 domain binds to its targets by recognizing a phosphotyrosine (pY) in a pYxNx peptide motif, requiring an Asn at the +2 position C-terminal to the pY with the residue either side of this Asn being hydrophobic. Structural analysis of the Grb2 SH2 domain in complex with its cognate peptide has shown that the peptide adopts a unique β-turn conformation, unlike the extended conformation that phosphopeptides adopt when bound to other SH2 domains. TrpEF1 (W121) is believed to force the peptide into this unusual conformation conferring this unique specificity to the Grb2 SH2 domain. Using X-ray crystallography, electron paramagnetic resonance (EPR) spectroscopy, and isothermal titration calorimetry (ITC), we describe here a series of experiments that explore the role of TrpEF1 in determining the specificity of the Grb2 SH2 domain. Our results demonstrate that the ligand does not adopt a pre-organized structure before binding to the SH2 domain, rather it is the interaction between the two that imposes the hairpin loop to the peptide.
Abstract
The adaptor protein Grb2 is a key element of mitogenetically important signaling pathways. With its SH2 domain it binds to upstream targets while its SH3 domains bind to downstream proteins thereby relaying signals from the cell membranes to the nucleus. The Grb2 SH2 domain binds to its targets by recognizing a phosphotyrosine (pY) in a pYxNx peptide motif, requiring an Asn at the +2 position C-terminal to the pY with the residue either side of this Asn being hydrophobic. Structural analysis of the Grb2 SH2 domain in complex with its cognate peptide has shown that the peptide adopts a unique β-turn conformation, unlike the extended conformation that phosphopeptides adopt when bound to other SH2 domains. TrpEF1 (W121) is believed to force the peptide into this unusual conformation conferring this unique specificity to the Grb2 SH2 domain. Using X-ray crystallography, electron paramagnetic resonance (EPR) spectroscopy, and isothermal titration calorimetry (ITC), we describe here a series of experiments that explore the role of TrpEF1 in determining the specificity of the Grb2 SH2 domain. Our results demonstrate that the ligand does not adopt a pre-organized structure before binding to the SH2 domain, rather it is the interaction between the two that imposes the hairpin loop to the peptide.
Furthermore, we find that the peptide adopts a similar structure when bound to both the wild-type Grb2 SH2 domain and a TrpEF1Gly mutant. This suggests that TrpEF1 is not the determining factor for the conformation of the phosphopeptide.
Introduction
Src Homology 2 (SH2) domains are protein modules found in many signal transduction proteins. They mediate protein-protein interactions during signaling by specifically recognizing and binding to tyrosine-phosphorylated sites 1 . Although there have been extensive investigations aiming to understand how SH2 domains specifically recognize tyrosine-phosphorylated peptides (reviewed in Liu et al., 2012 2 ), some aspects of the mechanism that controls the interactions of SH2 domains with their targets still remain to be explored. One case in point is the SH2 domain of the adaptor protein Grb2.
The Grb2 SH2 domain belongs to a small group of 18 SH2 domains that show a strong binding proclivity for an Asn residue at the +2 position C-terminal of the phosphotyrosine (pY), with the general binding motif being pYxNx, where x can be any hydrophobic residue 3 . The SH2 domains of the Grb2/Grap/Gads family and Grb7 have been identified to recognize the pYxNx motif in vivo 4, 5, 6, 7 . In the conventional SH2 domain binding mode (exemplified by the SH2 domain of the Src kinase 8, 9 ), the phosphorylated peptide usually binds to the SH2 domain in an extended, linear, conformation; the phosphotyrosine (pY) binds to a distinct pocket termed the "pY-binding" pocket of the domain while the sequence of the residues adjacent to the pY mediates binding specificity. In the case of the archetypal SH2 domain of the Src kinase (Src SH2 domain), binding specificity is primarily mediated by the interactions between another distinct pocket in the SH2 domain termed the "+3 specificity determining region/pocket" and the ligand's third (+3) residue C-terminal to the pY. However, in the case of the Grb2 SH2 domain, structural analysis of the domain bound to its cognate peptide has disclosed a unique peptide conformation 10, 11, 12 . When bound to the Grb2 SH2 domain the peptide adopts a type I β-turn conformation, with the +2 Asn forming a network of hydrogen bonds with residues of the domain. The different binding mechanism of the Grb2 SH2 domain was attributed to the composition and structure of its EF loop (the naming of the secondary structures follows the nomenclature introduced by Eck et al, 1994 13 ). For the Grb2 SH2 domain, a Trp at the EF1 position of the loop (W121 or TrpEF1) is considered to be the key residue for its specificity [10] [11] [12] 14 . With its bulky sidechain, TrpEF1 appears to force the peptide into the hairpin conformation exposing the +2 Asn prominently for binding 10, 11, 12 .
The importance of TrpEF1 for the molecular recognition mechanism of the Grb2 SH2 domain has been demonstrated in several studies, the most detailed of which established that a mutation to Trp at the EF1 position of the Src SH2 domain resulted in the switch of its specificity to that of Grb2 14 . The Src SH2 domain binds preferentially to phosphopeptides with two Glu residues at the +1 and +2 positions and an Ile at the +3 position C-terminal to the pY (motif pYEEI) 3, 15 . However, the introduction of a Trp at the EF1 position of the Src SH2 domain (ThrEF1Trp mutant) led to a 20-fold decrease in affinity for its pYEEI cognate peptide and to a 60-fold increase for a peptide containing the Grb2-specific pYVNV motif 14 . Moreover, the Src SH2 ThrEF1Trp domain mutant behaves biologically like a Grb2 SH2 domain would, restoring vulva induction in C.elegans with a vulvaless phenotype 14 . Co-crystallization of the ThrEF1Trp mutant Src SH2 domain with a pYVNV motif-containing phosphopeptide revealed a mode of binding similar to that of the wild-type Grb2 SH2 domain/pYVNV peptide interaction 16 . Superimposition of the wild-type Grb2 SH2 domain/pYVNV peptide complex with the ThrEF1Trp mutant Src SH2 domain/pYVNV complex showed that the TrpEF1 in both structures is capable of forming stabilizing interactions with the ligands, and as a result, the peptides in the two structures make identical interactions and form a similar β turn 16 . This was a groundbreaking finding in the study of the selectivity of SH2 domains suggesting that mutating a single residue is enough to switch the specificity of an SH2 domain.
In the study presented here, a mutant Grb2 SH2 domain, in which a far less bulky Gly replaced TrpEF1 (TrpEF1Gly), was constructed in order to further investigate the importance of the EF1 position for the specificity of the Grb2 SH2 domain. We hypothesized that the substitution of TrpEF1 by Gly would relieve the constraints that appear to impose a β-turn conformation on the phosphopeptide ligand, resulting in the peptide binding in an extended, linear, conformation as observed for most SH2 domain ligands. We co-crystallized the mutant Grb2 SH2 domain with the SpYVNVQ peptide, which represents the Grb2 binding site at Tyr-317 of the human Shc protein, a native target of the Grb2 SH2 domain. The structure revealed a domain-swapped dimer where, surprisingly, the peptide binds in a similar mode as in the wild-type Grb2 SH2 domain, indicating that a Trp at position EF1 is not required to force a turn conformation on the peptide. This surprising result was confirmed by investigating the interaction of the peptide with wild-type and mutant Grb2 SH2 domains in solution using Electron Paramagnetic Resonance (EPR) spectroscopy in conjunction with nitroxide spin-labeling 17, 18 . The structure of the pYVNV motifcontaining peptide alone was also investigated and found to be flexible suggesting that the bound turn conformation is indeed imposed by binding.
Finally, in order to investigate the possibility that the TrpEF1Gly mutation of the Grb2 SH2 domain might have switched the binding specificity to that of Src, ITC experiments were performed on both mutant and wild-type SH2 domains of both Src and Grb2, the results demonstrating that i-a TrpEF1Gly mutation in the Grb2 SH2 domain reduces binding of its cognate peptide by only 10-fold and increases binding of the Src-specific pYEEI peptide by only 6-fold, ii-conversely, a ThrEF1Trp mutation in the Src SH2 domain results in only a modest affinity gain of about 7-fold to the Grb2-specific pYVNV peptide while decreasing affinity to its cognate pYEEI peptide by 6-fold. We thus conclude that the position EF1 in both Grb2 and Src SH2 domains only plays a minor role in both peptide conformation and binding specificity.
Results and Discussion
Crystal structure of the Grb2 SH2 TrpEF1Gly domain in a complex with a pYxNx motif-containing peptide During the purification, both wild-type Grb2 SH2 domain and the TrpEF1Gly mutant eluted in a dimeric and monomeric state. The concentration of the two states was equal for the wild-type domain while the proportion of monomers was higher (80%) for the mutant (results not shown). In all the experiments described below, only the monomeric fraction was used. However, the crystal structure revealed a domain-swapped dimer, which agrees with previous findings that the domain-swapped dimer is metastable 19 .
The complex of the Grb2 SH2 domain bound to the SpYVNVQ peptide crystallized with 32 molecules in the asymmetric unit; 16 SH2 domains forming The wild-type Grb2 SH2 domain has been crystalized in a domainswapped mode previously 12, 19, 20, 21 . The structure of the Grb2 SH2 TrpEF1Gly domain is comparable to the previously described structures with the main 
EPR spectroscopy of the interaction of the Grb2 SH2 domain with its cognate binding motif
We used EPR spectroscopy in order to obtain structural information for the interaction of the wild-type Grb2 SH2 and the TrpEF1Gly Grb2 SH2 domains with the pYVNV peptide in solution. For the experiments, a peptide with two cysteine residues at the N-and C-terminus, respectively, was used (sequence CSpYVNVQC). The covalent modification of this peptide with two nitroxide spin labels using a monobromo-maleimide spin label is described in the Materials and Methods section. Line broadening in continuous-wave (cw)-EPR spectroscopy experiments at ambient temperature confirmed the interaction of the labeled peptide with both the wild-type and the mutant Grb2 SH2 domains (Figure 2A ).
Binding of the peptide was observed via line broadening and a reduced high-field peak intensity of the bound form(s) when compared to the apo form ( Figure 2A ). EPR distance measurements using the 4-pulse DEER sequence 23 These data indicate that the peptide behaves in a comparable way when bound to both the wild-type and the Grb2 SH2 domain mutant confirming the crystallography data that a Trp residue at position EF1 is not the determining factor for the conformation of the phosphopeptide, as has been previously suggested 10, 12 . An EPR distance measurement was also recorded for the free peptide in solution ( Figure 2, C and D) . According to our data, when free in solution, the CSpYVNVQC peptide presents high mobility and adopts a wide range of conformations leading to a far broader distance distribution than for the boundpeptides. Note that spin-spin distances smaller than 1.5 nm are also likely to be present, but can not be directly observed by DEER as indicated by the dotted lines in Figure 2D . This result demonstrates that the ligand does not adopt a preorganized structure before binding to the SH2 domain and it is the interaction between the two that imposes the hairpin loop to the peptide.
ITC analysis of Src and Grb2 wild-type and mutant SH2 domains with their cognate peptides
ITC experiments were employed to probe the binding properties of both the wild-type and the Grb2 SH2 TrpEF1Gly domains to the Grb2-specific SpYVNVQ ligand and the PQpYEEIPI (Src-specific) ligand (Table 1 ). The substitution of the entropically driven. The decrease in affinity for the PQpYEEIPI peptide is readily explicable from the structure, as the indole ring of the Trp residue sterically prevents the interaction of the peptide's +3 residue with the specificity-binding pocket 16 . Moreover, the increase in the binding affinity of the Src SH2 ThrEF1Trp domain for the SpYVNVQ peptide could be partially explained from the Van der Waals bonds that TrpEF1 forms with the +2 Asn of the peptide 16 . These results differ from previously published data where, in SPR experiments, the specific point mutation of the Src SH2 domain led to a 20-fold decrease in affinity for a pYEEI-containing motif peptide (sequence EPQpYEEIPIYLK) and to a 60-fold increase for a pYVNV-containing peptide (sequence DPSpYVNVQNLDK) 14 .
Conclusion
The Grb2 SH2 domain has previously been shown to bind specifically to tyrosine-phosphorylated peptides with the pYxNx motif. Such peptides adopt a characteristic type I β-turn upon binding. This unique peptide conformation has been attributed to a Trp at the EF1 position of the SH2 domain, which is only found in the Grb2 SH2 domain and the closely related Grap and Gads SH2 domains. In our study, a Grb2 SH2 domain mutant where TrpEF1 is substituted to Gly binds to the pYVNV motif-containing ligand by forming a similar network of interactions as has been described for the wild-type Grb2 SH2 domain, suggesting that a Trp at this position does not impose constraints on the conformation of the peptide ligand. EPR analysis confirms that, in the bound state, the conformation of the peptide is the same whether bound to the wildtype and mutant SH2 domains, a conclusion reinforced by ITC results. These also indicate that Trp at position EF1 plays a much less important role than previously suggested as the reduction in affinity is only 10-fold compared to wild-type.
The pYVNV motif-containing peptide forms most of its interactions with the main chain atoms of the Grb2 SH2 domain, suggesting that any SH2 domain using its backbone hydrogen bonding capabilities could bind to some extent to a peptide with the pYxNx motif. This explains why the Src SH2 ThrEF1Trp domain binds with relatively high affinity to the SpYVNVQ peptide (this study and 14, 16 ).
However, the increased affinity of the Src SH2 ThrEF1Trp domain for the SpYNVNQ peptide is, in our hands, much less pronounced than previously reported: a 7-fold increase compared to a 60-fold increase by Marengere et al.
(1994) 14 . There is no structural evidence of the binding of the wild-type Src SH2 domain to a peptide bearing the pYxNx motif, but molecular dynamics simulations have suggested that a pYxNx motif-containing peptide would also adopt a β-turn conformation when bound to the Src SH2 domain 25 . In the same study the free energy of binding of the Src SH2 domain to a pYVNV motifcontaining peptide was estimated using fluorescent polarization binding assays to be -29.1 kJ/mol, which is in excellent agreement with the free energy measured in the ITC experiments reported here (ΔG = -29.08 kJ/mol). Consistent with these data, in vivo targets of Grb2 and Src SH2 domains have been identified where both domains recognize the same sequence 26, 27 .
Key to SH2 domain binding thermodynamics is the conformation of the peptide ligand in its unbound state 28, 29 . It has been suggested that decreasing conformational sampling might lower the entropic cost of binding. Studies have suggested that the SpYVNVQ peptide might be able to adopt a β-turn conformation in solution but the EPR data presented here suggest it does not and is instead conformationally flexible, implying a entropic cost component to its binding thermodynamics.
Detailed studies of Src SH2 domain binding thermodynamics have all pointed to the fact that the range of affinities within which SH2 domains appear to operate is relatively narrow. Until now, the Grb2 SH2 domain appeared to be an exception. However, our study demonstrates that this is not the case. Instead, our data confirm that the binding specificity of SH2 domains, even that of Grb2, results from multiple factors and does not depend merely on the nature of one particular residue.
Materials and Methods

DNA constructs.
The Grb2 SH2 domain in the pQE-60 vector was provided from Dr Stephen F.
Martin (University of Texas at Austin, TX, USA). The Src SH2 domain, in the pET3a plasmid, was as described in Waksman et al., 1992 8 .
Peptides
The peptides used in this study were synthesized by Biosynthesis Inc (Lewisville, TX). The sequences of the peptides that are described in this study are the following; SpYVNVQ: Ac-S(pY)VNVQ-CONH2, CSpYVNVQC: Ac-CS(pY)VNVQC-CONH2, PQpYEEIPI: Ac-PQ(pY)EEIPI-CONH2. The purity of the peptides was assessed by HPLC and ESI-MS. The extinction coefficient used was determined as described by Bradshaw et al., 1998 30 .
Site-directed mutagenesis
All mutagenesis was carried out using the QuikChange protocol (Stratagene, 2004), a PCR-based technique for site-directed mutagenesis. Forward and reverse mutagenic oligonucleotide primers were designed in accordance with the QuikChange protocol ( Table 2 ). The KOD Hot Start DNA Polymerase (Novagen) was used in all the mutagenesis experiments.
Protein Purification
Ni-NTA chromatography was used for the purification of the Grb2 SH2 domain constructs. The cells expressing the 6His-tagged proteins were lysed in 0.1 M Sodium Phosphate pH 7.2, 300 mM NaCl, 50 mM Imidazole. After clarification the lysate was passed through a 5 ml Ni-NTA Superflow column (Qiagen), connected to an AKTA Prime (GE Healthcare), at a flow rate of 1.5 ml/min. The column was washed using 10 column volumes of the binding buffer and the Grb2 SH2 domain constructs were eluted using 300 mM Imidazole, 0.1M Sodium Phosphate pH 7.2, 300 mM NaCl. Fractions containing the 6His-tagged SH2 domains were identified using SDS-PAGE gels, pooled and concentrated. For the Src SH2 domain constructs, the cells were lysed in 0.1 M Sodium Phosphate pH 7.0, 1 mM EDTA, 5 mM DTT and after clarification the lysate was applied to an SP-sepharose column (GE Healthcare) connected to an AKTA Prime. Bound proteins were eluted using a 0-1M NaCl gradient. Fractions containing the SH2 domain constructs were identified using SDS-PAGE gels, pooled and concentrated.
After the first purification step the eluent was concentrated to 2-3 mls using Amicon centrifuge devices with a 3 kDa cut-off and then loaded to a prepacked Sephacryl S-100 column (GE Healthcare) using an AKTA Prime system. The column was pre-equilibrated in a gel filtration buffer, the composition of which was dependent on the type of experiments the samples were subsequently subjected to, and run at 0.8 ml/min. Fractions containing the appropriate peaks, as assessed by SDS-PAGE, were pooled and concentrated.
Crystallization experiments
Grb2 SH2 TrpEF1Gly domain with a C-terminal 6His-tag was purified by affinity and size exclusion chromatography and its purity was assessed by SDS-PAGE.
Before setting up crystal trials the buffer of the protein was exchanged to 50 mM Sodium Cacodylate pH 6.5 by ultrafiltration using Amicon centrifugation devices with 3 kDa cut-off. The protein was then concentrated to ∼20-40 mg/ml. The SpYVNVQ peptide was dissolved in the same buffer and added to the protein at a 1:1.5 molar ratio.
Crystallization experiments were performed by vapour diffusion using the hanging drop method with reservoirs containing 0.2 M Sodium Thiocyanate, Potassium Thiocyanate between 0.31 M to 0.3975 M, and the PEG-8000 between 28% to 33% (w/v)). The optimal crystals were grown at 0.335 M Potassium thiocyanate, 31% (w/v) PEG 8000. Crystals and cryoprotectants were tested with the in house Rigaku RA-Micro7 HFM tabletop rotating anode X-ray generator. Datasets were collected at the beamline ID29 at the ESRF synchrotron radiation facility in France and at the Proxima1 microfocus beamline with an ADSC Quantum 315r CCD detector at the SOLEIL synchrotron radiation facility in France.
Images were processed using the XDS software package 31 . BALBES 32 was used for molecular replacement and ligand building and structure manipulation Table 3 for data collection and final refinement statistics).
EPR Spectroscopy
Spin-Labeling.
Labeling of the CSpYVNVQC peptide was attempted with MTSSL (Sigma-Aldrich) according to standard protocols. However, labeling resulted in greatly reduced solubility and thus a monobromo-maleimide (3-bromo-2,5-dioxo-2,5-dihydropyrrole-1-carboxylic acid methyl ester) spin label was synthesized in analogy to the dibromo-maleimide (3,5-dibromo-2,5-dioxo-2,5-dihydro-pyrrole-1-carboxylic acid methyl ester) described in Schumacher et al. 2013 35 .
The label was dissolved in 100% DMF at a concentration of 10 mM and was added in 0.2 mM of peptide (20 mM Hepes pH 7.5, 150 mM NaCl, 5 mM EDTA) to reach a 1:2 peptide/label molar ratio. The reaction was incubated at room temperature for 2 hours in the dark. The labeling was assessed using ESI-MS and the yield calculated to be 97%.
Cw-EPR.
The protein (200 µM) was mixed with the peptide (1:0.5 ratio of protein:
peptide, to ensure that all the peptide molecules are in a bound state) in 20 mM Hepes pH 7.5, 150 mM NaCl. Cw-EPR experiments at ambient temperature were performed on a EMXPlus EPR spectrometer (Bruker Biospin) operating at XBand (9.7 GHz, 0.3 T) equipped with a 4122SHC resonator. All measurements were carried out with 2 mW microwave power, 100 kHz modulation frequency, 0.1 mT modulation amplitude and 20 ms conversion time and time constant.
EPR distance measurements.
The protein (50 µM) was mixed with the peptide (1:0.5 ratio of protein) in 20 mM Hepes at pH 7.5, 150 mM NaCl. 5% glycerol was added and the samples were frozen in liquid N2. Experiments were performed at 50 K on an ELEXSYS E580 EPR spectrometer (Bruker Biospin) operating at X-Band (9.2 GHz, 0.3 T)
equipped with an ER-4118-X-MS-3W resonator. The four-pulse DEER sequence 21 was chosen with π/2obs −τ1 −πobs −(τ1 +t) −πpump −(τ2 −t) −πobs −τ2 −echo, where the observer pulse length was 16 ns for π/2 and 32 ns for π pulses. The pump pulse length was 12 ns, the long interpulse delay was t = 2 µs. All other the raw data titration and lower panels show the data and best-fit curves obtained from data analysis using a single site model.
